NEWS

Dr. Byram Bridle: Moderna admitted it did not ‘optimize’ COVID jab quality control

Updated: August 15, 2023 at 3:58 pm EST  See Comments

Tue Aug 15, 2023 – 3:03 pm EDTTue Aug 15, 2023 – 3:00 pm EDT

MARKHAM, Ontario (LifeSiteNews) –– Big Pharma’s Moderna has admitted that they did not have an optimal quality control system in place when they rolled out their mRNA jabs, that they could not accurately control the dose, and that they did not know where the mRNA was being distributed in the human body.  

“This is breaking news,” announced Dr. Byram Bridle at LifeSiteNews’ annual general meeting near Toronto on July 19 and presented on the large screen behind him an article produced by Montreal’s McGill University. The article was entitled “McGill University and Moderna to expand collaborations with new projects in Lipid Nanoparticle research.”  

“Remember, lipid nanoparticles are the foundation for the mRNA vaccine,” Bridle said. “That’s what they even talk about in this article.” 

Before discussing the actual research projects, Bridle drew his audience’s attention to the partnership between Big Pharma and the publicly funded university.  

“First of all, recognize that…this is not a new collaboration. They’re ‘expanding’ collaboration. So, there are conflicts of interest that you need to be aware of. There’s nothing wrong with this per se,” the vaccinologist

The remainder of this article is available in its entirety at LifeSite News

The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors

Advertisement
Ledger Nano S Cryptocurrency Wallet
0 0 votes
Article Rating
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments
A Quick Note…

Already a subscriber? Login to remove advertisements. Not a subscriber? Join the Official Street Preachers and gain access to hundreds of presentations and exclusives that cover today's events and how they impact you, your life, and your soul. All while supporting independent Christian researchers trying to make a difference.